메뉴 건너뛰기




Volumn , Issue , 2008, Pages 193-200

18F-fluorodeoxyglucose positron emission tomography in oncology: Advantages and limitations

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84855320299     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374212-4.50090-0     Document Type: Chapter
Times cited : (2)

References (51)
  • 1
    • 0347357747 scopus 로고    scopus 로고
    • Implications of PET based molecular imaging on the current and future practice of medicine
    • Alavi A., Kung J.W., Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Semin. Nucl. Med. 2004, 34:56-69.
    • (2004) Semin. Nucl. Med. , vol.34 , pp. 56-69
    • Alavi, A.1    Kung, J.W.2    Zhuang, H.3
  • 2
    • 2842561598 scopus 로고    scopus 로고
    • Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndromes)
    • Alberini J-L., Belhocine T., Hustinx R., Daenen F., Rigo P. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndromes). Nucl. Med. Commun. 2003, 24:1081-1086.
    • (2003) Nucl. Med. Commun. , vol.24 , pp. 1081-1086
    • Alberini, J.-L.1    Belhocine, T.2    Hustinx, R.3    Daenen, F.4    Rigo, P.5
  • 7
    • 0037315245 scopus 로고    scopus 로고
    • Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT
    • Cohade C., Osman M., Pannu H.K., Wahl R.L. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J. Nucl. Med. 2003, 44:170-176.
    • (2003) J. Nucl. Med. , vol.44 , pp. 170-176
    • Cohade, C.1    Osman, M.2    Pannu, H.K.3    Wahl, R.L.4
  • 8
    • 0031967456 scopus 로고    scopus 로고
    • FDG PET for detection and therapy control of metastatic germ cell tumor
    • Cremerius U., Effert P.J., Adam G., et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J. Nucl. Med. 1998, 39:815-822.
    • (1998) J. Nucl. Med. , vol.39 , pp. 815-822
    • Cremerius, U.1    Effert, P.J.2    Adam, G.3
  • 9
    • 0029355220 scopus 로고
    • 18FDG whole-body PET in differentiating thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 1311
    • Feine U., Lietzenmayer R., Hanke J.P., Wohrle H., Muller-Schauenburg W. 18FDG whole-body PET in differentiating thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 1311. Nuklearlmedizin 1995, 34:127-134.
    • (1995) Nuklearlmedizin , vol.34 , pp. 127-134
    • Feine, U.1    Lietzenmayer, R.2    Hanke, J.P.3    Wohrle, H.4    Muller-schauenburg, W.5
  • 11
    • 0036411742 scopus 로고    scopus 로고
    • Clinical trial design for target-based therapy
    • Fox E., Curt G.A., Balis F.M. Clinical trial design for target-based therapy. Oncologist 2002, 7:401-409.
    • (2002) Oncologist , vol.7 , pp. 401-409
    • Fox, E.1    Curt, G.A.2    Balis, F.M.3
  • 12
    • 0018166544 scopus 로고
    • Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose
    • Gallagher B.M., Fowler J.S., Gutterson N.I., MacGregor R.R., Wan C.N., Wolf A.P. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J. Nucl. Med. 1978, 19:1154-1161.
    • (1978) J. Nucl. Med. , vol.19 , pp. 1154-1161
    • Gallagher, B.M.1    Fowler, J.S.2    Gutterson, N.I.3    MacGregor, R.R.4    Wan, C.N.5    Wolf, A.P.6
  • 13
  • 14
    • 0042242676 scopus 로고    scopus 로고
    • The glycolytic phenotype in carcinogenesis and tumor invasion
    • Gatenby R.A., Gawlinski E.T. The glycolytic phenotype in carcinogenesis and tumor invasion. Cancer. Res. 2003, 63:3847-3854.
    • (2003) Cancer. Res. , vol.63 , pp. 3847-3854
    • Gatenby, R.A.1    Gawlinski, E.T.2
  • 15
    • 2942642492 scopus 로고    scopus 로고
    • Posttherapy [18F] Fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome
    • Grigsby P.W., Siegel B.A., Dehdashti F., Rader J., Zoberi I. Posttherapy [18F] Fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J. Clin. Oncol. 2004, 22:2167-2171.
    • (2004) J. Clin. Oncol. , vol.22 , pp. 2167-2171
    • Grigsby, P.W.1    Siegel, B.A.2    Dehdashti, F.3    Rader, J.4    Zoberi, I.5
  • 16
    • 3142626455 scopus 로고    scopus 로고
    • Quantification in clinical fluorodeoxyglucose positron emission tomography
    • (Review)
    • Hallett W.A. Quantification in clinical fluorodeoxyglucose positron emission tomography. Nucl. Med. Commun. 2005, 25:647-650. (Review).
    • (2005) Nucl. Med. Commun. , vol.25 , pp. 647-650
    • Hallett, W.A.1
  • 17
    • 0022885139 scopus 로고
    • Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
    • Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 1986, 27:235-238.
    • (1986) J. Nucl. Med. , vol.27 , pp. 235-238
    • Hamacher, K.1    Coenen, H.H.2    Stocklin, G.3
  • 18
    • 0036384894 scopus 로고    scopus 로고
    • Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
    • Hany T.F., Gharehpagagh E., Kamel E.M. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur. J. Nucl. Med. Mol. Imaging. 2002, 29:1393-1398.
    • (2002) Eur. J. Nucl. Med. Mol. Imaging. , vol.29 , pp. 1393-1398
    • Hany, T.F.1    Gharehpagagh, E.2    Kamel, E.M.3
  • 19
    • 0016374648 scopus 로고
    • Transport of sugars in tumor cell membranes
    • Hatanaka M. Transport of sugars in tumor cell membranes. Biochem. Biophys. Acta. 1974, 355:77-104.
    • (1974) Biochem. Biophys. Acta. , vol.355 , pp. 77-104
    • Hatanaka, M.1
  • 20
    • 28444469710 scopus 로고    scopus 로고
    • Very early detection of response to imatinib mesylate therapy of gastroinstestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography
    • Heinicke T., Wardelmann E., Sauerbruch T., et al. Very early detection of response to imatinib mesylate therapy of gastroinstestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer. Res. 2005, 25:4591-4594.
    • (2005) Anticancer. Res. , vol.25 , pp. 4591-4594
    • Heinicke, T.1    Wardelmann, E.2    Sauerbruch, T.3
  • 21
    • 0034909182 scopus 로고    scopus 로고
    • Pattern of uptake and excretion of (18)F-FDG in the lactating breast
    • Hicks R.J., Binns D., Stabin M.G. Pattern of uptake and excretion of (18)F-FDG in the lactating breast. J. Nucl. Med. 2001, 42:1238-1242.
    • (2001) J. Nucl. Med. , vol.42 , pp. 1238-1242
    • Hicks, R.J.1    Binns, D.2    Stabin, M.G.3
  • 22
    • 33845363671 scopus 로고    scopus 로고
    • 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference
    • 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann. Oncol. 2006, 17:1761-1765.
    • (2006) Ann. Oncol. , vol.17 , pp. 1761-1765
    • Hoffmann, M.1    Wohrer, S.2    Becherer, A.3    Chott, A.4    Streubel, B.5    Kletter, K.6    Raderer, M.7
  • 23
    • 0032879180 scopus 로고    scopus 로고
    • Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
    • Hustinx R., Smith R.J., Benard F., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur. J. Nucl. Med. 1999, 26:1345-1348.
    • (1999) Eur. J. Nucl. Med. , vol.26 , pp. 1345-1348
    • Hustinx, R.1    Smith, R.J.2    Benard, F.3
  • 24
    • 33746444445 scopus 로고    scopus 로고
    • Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET
    • Jackson R.S., Schlarman T.C., Hubble W.L., Osman M.M. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J. Nucl. Med. Technol. 2006, 34:29-33.
    • (2006) J. Nucl. Med. Technol. , vol.34 , pp. 29-33
    • Jackson, R.S.1    Schlarman, T.C.2    Hubble, W.L.3    Osman, M.M.4
  • 26
    • 0034948354 scopus 로고    scopus 로고
    • Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's Lymphoma (NHL)
    • Jerusalem G., Beguin Y., Najjar F., et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's Lymphoma (NHL). Ann. Oncol. 2001, 12:825-830.
    • (2001) Ann. Oncol. , vol.12 , pp. 825-830
    • Jerusalem, G.1    Beguin, Y.2    Najjar, F.3
  • 27
    • 33745278885 scopus 로고    scopus 로고
    • Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization
    • Kaneta T., Hakamatsuka T., Takanami K., et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann. Nucl. Med. 2006, 20:203-208.
    • (2006) Ann. Nucl. Med. , vol.20 , pp. 203-208
    • Kaneta, T.1    Hakamatsuka, T.2    Takanami, K.3
  • 28
    • 0033255382 scopus 로고    scopus 로고
    • Visualization of normal organs in whole-body FDG-PET imaging
    • Kato F., Tsukamoto E., Suginami Y., et al. Visualization of normal organs in whole-body FDG-PET imaging. Kaku. Igaku. 1999, 36:971-977.
    • (1999) Kaku. Igaku. , vol.36 , pp. 971-977
    • Kato, F.1    Tsukamoto, E.2    Suginami, Y.3
  • 29
    • 0026539682 scopus 로고
    • Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography
    • Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992, 33:1972-1980.
    • (1992) J. Nucl. Med. , vol.33 , pp. 1972-1980
    • Kubota, R.1    Yamada, S.2    Kubota, K.3    Ishiwata, K.4    Tamahashi, N.5    Ido, T.6
  • 30
    • 33644817639 scopus 로고    scopus 로고
    • Potential of dual time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET
    • Kumar R., Loving V.A., Chauhan A., Zhuang H., Mitchell S., Alavi A. Potential of dual time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J. Nucl. Med. 2005, 46:1819-1824.
    • (2005) J. Nucl. Med. , vol.46 , pp. 1819-1824
    • Kumar, R.1    Loving, V.A.2    Chauhan, A.3    Zhuang, H.4    Mitchell, S.5    Alavi, A.6
  • 31
    • 0029927549 scopus 로고    scopus 로고
    • FDG-PET screening for cerebral metastases in patients with suspected malignancy
    • Larcos G., Maisey M.N. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl. Med. Commun. 1996, 17:197-198.
    • (1996) Nucl. Med. Commun. , vol.17 , pp. 197-198
    • Larcos, G.1    Maisey, M.N.2
  • 32
    • 1542399591 scopus 로고    scopus 로고
    • 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT
    • 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J. Nucl. Med. 2004, 45:266-271.
    • (2004) J. Nucl. Med. , vol.45 , pp. 266-271
    • Lerman, H.1    Metser, U.2    Grisaru, D.3
  • 33
    • 0027505656 scopus 로고
    • Influence of the blood glucose concentration on FDG uptake in cancer-a PET study
    • Lindholm P., Minn H., Leskinen-Kallio S. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J. Nucl. Med. 1993, 34:1-6.
    • (1993) J. Nucl. Med. , vol.34 , pp. 1-6
    • Lindholm, P.1    Minn, H.2    Leskinen-kallio, S.3
  • 34
    • 0036452450 scopus 로고    scopus 로고
    • Overview of clinical PET
    • Maisey M.N. Overview of clinical PET. Br. J. Radiol. 2002, 75:S1-S5.
    • (2002) Br. J. Radiol. , vol.75
    • Maisey, M.N.1
  • 36
    • 0026801196 scopus 로고
    • Type 1 glucose transporter from the mouse which are responsive to serum, growth factors, and oncogenes
    • Mukarami T., Nishiyama T., Shirotani T., et al. Type 1 glucose transporter from the mouse which are responsive to serum, growth factors, and oncogenes. J. Biol. Chem. 1992, 267:9300-9306.
    • (1992) J. Biol. Chem. , vol.267 , pp. 9300-9306
    • Mukarami, T.1    Nishiyama, T.2    Shirotani, T.3
  • 38
    • 0034241796 scopus 로고    scopus 로고
    • Inaugural article: positron emission tomography provides molecular imaging of biological processes
    • Phelps M.E. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:9226-9233.
    • (2000) Proc. Natl. Acad. Sci. U.S.A. , vol.97 , pp. 9226-9233
    • Phelps, M.E.1
  • 40
    • 0032080718 scopus 로고    scopus 로고
    • Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients
    • Rinne D., Baum R.P., Hor G., Kaufman R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998, 82:1664-1671.
    • (1998) Cancer , vol.82 , pp. 1664-1671
    • Rinne, D.1    Baum, R.P.2    Hor, G.3    Kaufman, R.4
  • 41
    • 0032616268 scopus 로고    scopus 로고
    • Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
    • Shreve P.D., Anzai Y., Wahl R.L. Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:61-77.
    • (1999) Radiographics , vol.19 , pp. 61-77
    • Shreve, P.D.1    Anzai, Y.2    Wahl, R.L.3
  • 42
    • 0032616268 scopus 로고    scopus 로고
    • Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
    • Shreve P.D., Anzai Y., Wahl R.L. Pifalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:150-151.
    • (1999) Radiographics , vol.19 , pp. 150-151
    • Shreve, P.D.1    Anzai, Y.2    Wahl, R.L.3
  • 43
    • 0037569527 scopus 로고    scopus 로고
    • FDG PET monitoring of tumour response to chemotherapy: does (18F)FDG uptake correlate with the viable tumour cell fraction?
    • Spaepen K., Stroobants S., Dupont P., et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does (18F)FDG uptake correlate with the viable tumour cell fraction?. Eur. J. Nucl. Med. Mol. Imag. 2003, 30:682-688.
    • (2003) Eur. J. Nucl. Med. Mol. Imag. , vol.30 , pp. 682-688
    • Spaepen, K.1    Stroobants, S.2    Dupont, P.3
  • 44
    • 0025845450 scopus 로고
    • The applications of PET in clinical oncology
    • Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J. Nucl. Med. 1991, 32:801-820.
    • (1991) J. Nucl. Med. , vol.32 , pp. 801-820
    • Strauss, L.G.1    Conti, P.S.2
  • 45
    • 0016441373 scopus 로고
    • A positron-emission transaxial tomograph for nuclear imaging (PETT)
    • Ter-Pogossian M.M., Phelps M.E., Hoffman E.J., Mullani N.A. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 1975, 114:89-98.
    • (1975) Radiology , vol.114 , pp. 89-98
    • Ter-pogossian, M.M.1    Phelps, M.E.2    Hoffman, E.J.3    Mullani, N.A.4
  • 46
    • 0032110744 scopus 로고    scopus 로고
    • A new look at the cyclotron for making short-lived isotopes. 1966-classical article
    • Ter-Pogossian M.M., Wagner H.N. A new look at the cyclotron for making short-lived isotopes. 1966-classical article. Sem. Nucl. Med. 1998, 28:202-212.
    • (1998) Sem. Nucl. Med. , vol.28 , pp. 202-212
    • Ter-pogossian, M.M.1    Wagner, H.N.2
  • 47
    • 0032888251 scopus 로고    scopus 로고
    • Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group
    • Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J. Clin. Oncol. 1999, 17:3201-3206.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 3201-3206
    • Vansteenkiste, J.F.1    Stroobants, S.G.2    Dupont, P.J.3
  • 48
    • 0026939275 scopus 로고
    • Positron emission tomography at the turn of the century: a perspective
    • Wagner H.N. Positron emission tomography at the turn of the century: a perspective. Semin. Nucl. Med. 1991, 22:285-288.
    • (1991) Semin. Nucl. Med. , vol.22 , pp. 285-288
    • Wagner, H.N.1
  • 50
    • 0032757213 scopus 로고    scopus 로고
    • Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group
    • Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer 1999, 35:1773-1782.
    • (1999) Eur. J. Cancer , vol.35 , pp. 1773-1782
    • Young, H.1    Baum, R.2    Cremerius, U.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.